Arsenal Medical has been awarded a $4M NIH CRP grant to advance the clinical development of NeoCast and strengthen the evidence base for next-generation liquid embolics.
Arsenal Medical awarded a $4M NIH CRP grant to advance the clinical development of NeoCast
